PIPages
Labs

Larry Jackson

Duke University, NC·Medicine & Clinical Research·Early-career

Atrial fibrillation is an irregular heart rhythm that raises the risk of stroke. Blood-thinning drugs called oral anticoagulants (OAC) lower that risk.

Fields

Medicine & Clinical Research

Public Health & Epidemiology

Topics

atrial fibrillation

oral anticoagulants

stroke prevention

Grants
1 known grant, through Dec 2026

What they work on

  1. Interview Black and White patients with non-valvular atrial fibrillation and their clinicians to identify barriers to and facilitators of shared decision making about oral anticoagulants, the blood thinners that prevent stroke.
  2. Develop a patient decision support tool that explains the risks and benefits of oral anticoagulants, and refine it through repeated rounds of evaluation with patients and clinicians.
  3. Run a pilot study to test whether the decision support tool is feasible and acceptable for supporting shared decision making among Black patients with atrial fibrillation, preparing for a future randomized trial.

More about the research

Yet Black patients with non-valvular atrial fibrillation (NVAF), the form not caused by heart valve disease, are less likely than White patients to receive these drugs, even though they face about three times the risk of NVAF-related stroke. Black patients are also more likely to be left out of decisions about their own care. This project asks whether helping patients and clinicians make the choice together, known as shared decision making, can narrow this gap.

Why it matters

Black patients with atrial fibrillation face a higher risk of stroke and death but are less likely to receive stroke-preventing blood thinners. A decision support tool that improves shared decision making could help these patients make informed, values-based choices, may raise anticoagulant use, and could reduce racial disparities in heart rhythm care.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation

NIH · Sep 2021 – Dec 2026

Closest labs

Laura Cabrera Trujillo

Pennsylvania State University, PA·Medicine & Clinical Research

Identify neuroethical concerns and decision-making needs about early versus late use of advanced neurotechnology, using interviews and validated instruments with patients, caregivers and clinicians.

Fenan Rassu

Johns Hopkins University, MD·Medicine & Clinical Research·Early-career

Measure how socioeconomic status affects use of pain psychology among patients with chronic low back pain, using a retrospective analysis of data from a multi-site trial in Baltimore and Salt Lake City.

Anna Pfenniger

Northwestern University, IL·Medicine & Clinical Research·Early-career

Map when and where endothelial dysfunction appears during atrial fibrillation, especially the shift from paroxysmal to persistent AF, in two large animal models of AF.

The school

Duke University: 61 labs on PI Pages, $1.6B a year on research, 417 research doctorates a year.

More about Duke University

Reach out

A start for your email. Fill in the brackets.